Sweet sweet corn
The increased value of fresh sweet corn over the last decade has led to an investigation into the characteristics that increase marketability.
The increased value of fresh sweet corn over the last decade has led to an investigation into the characteristics that increase marketability.1
To determine if there was an optimum phenotype or cultivar within a phenotype, sweetness was examined over three phenotypes, su, se and sh2, which were isolated to prevent cross-pollinization. Cultivars were grown on sandy loam soil and varying harvest dates of early, mature and late were arranged to determine the optimum harvest date for maximum flavour. High performance liquid chromatography was used to determine sucrose, fructose, glucose and total sugars content.
A panel was then set up to evaluate the sweetness of each phenotype and each harvest date, with the acceptability greatly correlating with the high performance liquid chromatography analysis for sucrose and total sugars (sweetness, R = 0.70 and 0.61; acceptability, R = 0.64 and 0.55). Sucrose correlated with the total sugars (R = 0.95). As the maturity of each harvest increased, the panel were able to identify differences in phenotypes more readily. They indicated no difference between se and sh2, though sucrose and total sugar levels were different between them. Sh2 was considered sweet and acceptable on all harvest dates, but su was only acceptable to the panel when it had been harvested earlier.
1. Teri A Hale et al., HortTechnology, 15(2), 313–317 (April–June 2005).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
